Overexpression of the c-erbB-2 protein in human breast tumor cell lines
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The c‐erbB‐2 proto‐oncogene is amplified in a high percentage of primary human breast tumors, suggesting that the overexpression of this gene may be involved in the development of human breast cancer. We have investigated five human breast tumor cell lines and have detected amplified c‐erbB‐2 gene copies in two of them. This amplification leads to overexpression of the c‐erbB‐2 protein. In addition, two other cell lines have elevated protein levels without gene amplification, suggesting that other mechanisms can lead to overexpression of the c‐erbB‐2 protein. These results are similar to those that we obtained during a study of primary breast tumors (Berger et al.: Cancer Res 48:1238–1243, 1988). These breast tumor cell lines should be useful for an analysis of c‐erbB‐2 expression and of the mechanisms that in some cases lead to overexpression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Analysis of the SK-BR-3 gDNA identified high levels of HER2 amplification that corresponds with the published copy number range (14–24 copies per diploid genome) (41,43–45,47).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [47]
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,909
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., & Waterfield, M. D. (1984) · Nature · doi:10.1038/307521a0 · Cited by 2,516
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Ribonucleic acid isolated by cesium chloride centrifugation
Glisin, V., Crkvenjakov, R., & Byus, C. (1974) · Biochemistry · doi:10.1021/bi00709a025 · Cited by 2,156
Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204
Research works printed but not linked: 2
- Berger MS, 1988, Cancer Res, 48, 1238
- Redmond SMS, 1988, Oncogene, 2, 259
Cited by
Items 101–109 of 109
Carr, I., & Pettigrew, N. M. (1991) · Clinical & Experimental Metastasis · doi:10.1007/bf01756384 · Cited by 3
“Amplification or over-expression of the gene is seen in cancer cell lines [ 39 ] and is widely held to be more frequent in aneuploid, highly malignant tumours, and to imply poor prognosis [24, 51,60, 66, 73].”
BackgroundHerceptin – from bedside to bench to clinic?
Cameron, D. (2007) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(07)70065-4 · Cited by 1
Relative Quantification of the HER2/neu Oncogene Using SYBR Green I
Woods, R. (2001) · Springer eBooks · doi:10.1007/978-3-642-59524-0_26 · Cited by 1
Seidman, A. D., Fornier, M. N., Esteva, F. J., Tan, L. K., Kaptain, S., Bach, A. M., Panageas, K. S., Arroyo, C. D., Valero, V., Currie, V. E., et al. (2001)
Deyev, S. M., Kutova, O. M., Lebedenko, E. N., Proshkina, G. M., Schulga, A. A., & Соколова, Е. А. (2017) · Springer eBooks · doi:10.1007/978-3-319-62870-7_59
“Cytotoxicity of the proteins was studied by the microculture tetrazolium test (MTT) [17] using adherent monolayer cell cultures expressing different amount of the HER2 receptor: SKBR-3 (HER2-overexpressing human breast adenocarcinoma, ATCC HTB-30TM) [13], SKOV-3 (HER2-overexpressing human ovarian adenocarcinoma, ATCC…”
MethodSayburn, A. (2014) · BMJ · doi:10.1136/sbmj.g6275
Herceptin® – from laboratory to cure in breast cancer?
Cameron, D. (2007) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520073702011
Hydrophobic Tag Protein Degraders: An Emerging Therapeutic Strategy for Cancer
Pineda, T. A., Kumar, S., Ghosal, G., Natarajan, A., & Karpf, A. R. (2026) · Pharmaceuticals · doi:10.3390/ph19091477
“Targeting and eliminating oncogenic proteins offers a promising approach for treating cancer [26,27].”
Metadata
- Authors
- Hynes, N. E., Gerber, H. A., Saurer, S., & Groner, B.
- Affiliations
- University Hospital of Bern (CH)
- University of Bern (CH)
- ORCID
- Hynes, Nancy E.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 1989-02
- Volume
- 39
- Issue
- 2
- Pages
- 167-173
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2060531515
- Cited by
- 109
- References
- 28
- Citations by year
- 2026: 1 · 2023: 1 · 2018: 1 · 2017: 2 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- c-erbB-2, HER2/neu, gene amplification, protein overexpression, breast cancer, breast cancer cell lines, proto-oncogenes
- MeSH terms
- Proto-Oncogene Mas, Breast Neoplasms, DNA, Neoplasm, Gene Amplification, Nucleic Acid Hybridization, Proto-Oncogene Proteins, RNA, Neoplasm, Tumor Cells, Cultured, Blotting, Southern, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.